Cargando…
Heterogeneity Analysis of Bladder Cancer Based on DNA Methylation Molecular Profiling
Bladder cancer is a highly complex and heterogeneous malignancy. Tumor heterogeneity is a barrier to effective diagnosis and treatment of bladder cancer. Human carcinogenesis is closely related to abnormal gene expression, and DNA methylation is an important regulatory factor of gene expression. The...
Autores principales: | Wang, Shuyu, Xu, Dali, Gao, Bo, Yan, Shuhan, Sun, Yiwei, Tang, Xinxing, Jiao, Yanjia, Huang, Shan, Zhang, Shumei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209659/ https://www.ncbi.nlm.nih.gov/pubmed/35747826 http://dx.doi.org/10.3389/fonc.2022.915542 |
Ejemplares similares
-
Identification of Prognostic Biomarkers for Bladder Cancer Based on DNA Methylation Profile
por: Zhang, Shumei, et al.
Publicado: (2022) -
A Novel DNA Methylation Signature as an Independent Prognostic Factor in Muscle-Invasive Bladder Cancer
por: Xu, Zhijie, et al.
Publicado: (2021) -
Genomic Heterogeneity and Clonal Evolution in Gastroesophageal Junction Cancer Revealed by Single Cell DNA Sequencing
por: Duan, Qingke, et al.
Publicado: (2021) -
DNA methylation profiling in Trisomy 21 females with and without breast cancer
por: Bejaoui, Yosra, et al.
Publicado: (2023) -
Molecular profiling and specific targeting of gemcitabine-resistant subclones in heterogeneous pancreatic cancer cell populations
por: Färber, Benedikt, et al.
Publicado: (2023)